The Pennant Group, Inc. PNTG R2K

Healthcare · Medical Care Facilities · United States

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. The Company was incorporated in 2019 and is headquartered in Eagle, Idaho.

Market & Price

Market Cap

$1.19B

Current Price

$34.25

High / Low (52W)

$36.90 / $22.07

Beta

1.28

Valuation

Stock P/E

39.83

Industry PE

23.65

Forward P/E

21.52

PEG Ratio

1.98

Book Value

$9.96

Price to Book

3.44

P/S

1.16

EV/EBITDA

25.94

Dividend Yield

Profitability & Returns

ROCE

6.37%

ROE

9.98%

ROA

4.09%

Profit Margin

2.96%

Op Margin

5.92%

EPS (Latest Qtr)

$0.24

EPS (TTM)

$0.86

Balance Sheet & Liquidity

Debt/Equity

1.17

Quick Ratio

0.99

Current Ratio

1.19

Debt

$454.15M

Total Assets

$968.18M

Current Assets

$167.41M

Working Capital

$20.14M

Ownership

Promoter Holding

5.04%

Chg in Prom Hold

FII / Inst Holding

94.98%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$1.68B

Total Revenue (TTM)

$1.02B

EBITDA

$64.90M

Free Cash Flow

$19.09M

Operating Cash Flow

$66.12M

Shares Outstanding

34.77M

Gross Margin

19.64%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

26.05%

Profit 5Y

64.51%

Revenue (YoY)

36.00%

Earnings (YoY)

9.10%

PROS

Compounding revenue at 26.0% over 5 years.
Profit CAGR of 64.5% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	PNTG The Pennant Group, Inc. R2K	34.25	39.83	$1.19B	-	6.37%	9.98%	26.05%	64.51%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	72.95M	77.91M	82.73M	88.40M	91.85M	92.74M	98.40M	105.66M	110.34M	111.92M	113.91M	116.32M	118.35M	126.46M	132.28M	140.19M	156.91M	168.75M	180.69M	-	209.84M	219.50M	229.04M	289.32M	285.36M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	180.46M	189.20M	197.49M	250.05M	245.76M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29.38M	30.30M	31.55M	39.27M	39.60M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16.73M	19.82M	21.36M	21.70M	22.30M
Operating Income	-	-	5.80M	1.83M	3.31M	1.93M	4.27M	6.08M	4.48M	1.61M	3.57M	1.70M	2.33M	-3.12M	7.14M	4.28M	6.26M	7.06M	8.52M	9.56M	10.79M	-	12.65M	10.48M	10.19M	17.57M	17.30M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.47M	14.01M	12.48M	19.88M	19.77M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.21M	1.20M	1.02M	3.25M	3.07M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11.38M	10.58M	9.40M	14.27M	14.09M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.85M	2.60M	2.52M	3.90M	3.79M
Net Income	3.38M	4.16M	4.37M	1.33M	3.49M	1.52M	2.98M	4.34M	4.41M	950.00K	2.65M	1.25M	1.01M	-2.68M	4.83M	1.85M	2.80M	4.38M	4.91M	5.69M	6.21M	-	7.78M	7.08M	6.08M	8.64M	8.52M
Diluted EPS	-	-	-	0.05	0.13	0.06	0.10	0.15	0.15	0.03	0.09	0.04	0.03	-0.09	0.16	0.06	0.09	0.15	0.16	0.18	0.20	-	0.22	0.20	0.17	0.24	0.24

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	250.99M	286.06M	338.53M	390.95M	439.69M	473.24M	544.89M	695.24M	947.71M
Cost of Revenue	-	-	-	-	-	414.66M	477.86M	601.48M	817.20M
Gross Profit	-	-	-	-	-	58.59M	67.04M	93.76M	130.50M
Operating Expenses	-	-	-	-	-	38.88M	41.80M	56.33M	79.61M
Operating Income	15.40M	20.63M	5.67M	18.92M	4.70M	19.70M	25.24M	37.43M	50.89M
EBITDA	-	-	-	-	-	17.61M	30.64M	44.44M	60.85M
Interest Expense	-	-	-	-	-	3.82M	5.92M	6.96M	6.68M
Pretax Income	-	-	-	-	-	8.89M	19.58M	31.37M	45.63M
Tax Provision	-	-	-	-	-	1.65M	5.67M	7.03M	11.87M
Net Income	9.87M	15.68M	2.55M	15.74M	2.70M	6.64M	13.38M	22.56M	29.58M
Diluted EPS	0.36	0.58	0.11	0.52	0.09	0.22	0.44	0.70	0.84

Compounded Sales Growth

5 Years:	26.05%
1 Year:	36.00%

Compounded Profit Growth

5 Years:	64.51%
1 Year:	9.10%

Stock Price Performance

1 Year:	+19.30%
6 Months:	+22.02%
3 Months:	+1.60%
1 Month:	+11.53%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	98.15M	447.75M	506.98M	-	512.12M	539.69M	679.52M	968.18M
Current Assets	-	-	-	-	-	-	73.82M	80.08M	122.86M	167.41M
Cash & Equivalents	-	-	-	-	-	-	2.08M	6.06M	24.25M	17.02M
Inventory	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	53.42M	61.12M	81.30M	123.11M
Total Liabilities	-	-	32.86M	376.64M	405.80M	-	386.46M	394.18M	367.56M	593.93M
Current Liabilities	-	-	29.55M	51.19M	89.02M	-	70.25M	71.55M	101.70M	147.26M
Long Term Debt	-	-	0	18.53M	8.28M	51.37M	62.89M	63.91M	-	168.84M
Total Debt	-	-	-	-	-	-	326.57M	329.63M	273.09M	453.16M
Total Equity	48.36M	59.92M	65.29M	71.11M	101.17M	-	121.01M	140.34M	293.28M	332.60M
Shares Outstanding	-	-	-	-	-	-	29.70M	29.95M	34.38M	34.63M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	17.25M	23.27M	9.55M	50.20M	-	9.04M	33.09M	39.30M	48.29M
Investing Cash Flow	-16.08M	-9.48M	-26.46M	-41.62M	-	-24.24M	-30.22M	-70.68M	-227.97M
Financing Cash Flow	-1.16M	-13.79M	17.27M	-8.95M	-	12.08M	1.11M	49.57M	172.46M
Capital Expenditure	-3.13M	-3.60M	-6.71M	-7.25M	-	-14.17M	-8.11M	-8.99M	-12.04M
Free Cash Flow	14.12M	19.67M	2.84M	42.95M	-	-5.13M	24.98M	30.31M	36.26M
Net Change in Cash	-	-	-	-	-	-3.11M	3.98M	18.19M	-7.22M
Share Buybacks	-	0	0	65.00K	0	0	-	-	-
Dividends Paid	0	0	11.60M	0	0	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	12.4%	12.3%	13.5%	13.8%
Operating Margin %	6.1%	7.2%	1.7%	4.8%	1.1%	4.2%	4.6%	5.4%	5.4%
Net Margin %	3.9%	5.5%	0.8%	4.0%	0.6%	1.4%	2.5%	3.2%	3.1%
ROE %	16.5%	24.0%	3.6%	15.6%	-	5.5%	9.5%	7.7%	8.9%
ROCE %	-	30.1%	1.4%	4.5%	-	4.5%	5.4%	6.5%	6.2%

Shareholding Pattern

Insiders

5.04%

Institutions

94.98%

Public Float

100.02%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	7.81%	2.72M	$93.03M
2	Van Berkom & Associates Inc.	7.68%	2.67M	$91.43M
3	Turtle Creek Asset Management Inc.	4.55%	1.58M	$54.21M
4	Vanguard Capital Management LLC	4.17%	1.45M	$49.70M
5	Wasatch Advisors LP	4.08%	1.42M	$48.59M
6	Paradigm Capital Management	4.05%	1.41M	$48.25M
7	FMR, LLC	3.17%	1.10M	$37.76M
8	Provident Investment Management, Inc.	2.83%	983.01K	$33.67M
9	Ophir Asset Management Pty Ltd	2.60%	903.88K	$30.96M
10	Ameriprise Financial, Inc.	2.51%	872.18K	$29.87M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PNTG

No recent headlines available.

PNTG · Healthcare